• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Cancer Biomarkers: The Urokinase Plasminogen Activator System: Molecular Mechanisms and Clinical Relevance

    Cancer Biomarkers: The Urokinase Plasminogen Activator System by Schmitt, Manfred; Foekens, John; Sweep, Fred C.G.J.;

    Molecular Mechanisms and Clinical Relevance

      • GET 5% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice EUR 129.95
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        53 896 Ft (51 330 Ft + 5% VAT)
      • Discount 5% (cc. 2 695 Ft off)
      • Discounted price 51 202 Ft (48 764 Ft + 5% VAT)

    53 896 Ft

    Availability

    Uncertain availability. Please turn to our customer service.

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Edition number 1
    • Publisher De Gruyter
    • Date of Publication 15 January 2021

    • ISBN 9783110283396
    • Binding Hardback
    • No. of pages460 pages
    • Size 240x170 mm
    • Language English
    • Illustrations 50 Illustrations, black & white
    • 0

    Categories

    Long description:


    The serine protease urokinase-type plasminogen activator, its inhibitor and its receptor are considered the most valuable prognostic cancer biomarkers relevant to predict the clinical course of cancer patients and their response to cancer therapy. They are also among the few biomarkers that have been evaluated successfully in clinical studies for their clinical utility, for the most part in early breast cancer. This work provides an overview of the molecular mechanisms and clinical outlook of this important proteolytic system.

    More
    Recently viewed
    previous
    Cancer Biomarkers: The Urokinase Plasminogen Activator System: Molecular Mechanisms and Clinical Relevance

    Cancer Biomarkers: The Urokinase Plasminogen Activator System: Molecular Mechanisms and Clinical Relevance

    Schmitt, Manfred; Foekens, John; Sweep, Fred C.G.J.;(ed.)

    53 896 HUF

    51 202 HUF

    Cancer Biomarkers: The Urokinase Plasminogen Activator System: Molecular Mechanisms and Clinical Relevance

    LASEK, PRK, and Excimer Laser Stromal Surface Ablation

    Azar, Dimitri T.; Camellin, Massimo; Yee, Richard W.; (ed.)

    58 763 HUF

    52 887 HUF

    Cancer Biomarkers: The Urokinase Plasminogen Activator System: Molecular Mechanisms and Clinical Relevance

    Walden and Other Writings (The Norton Library)

    Thoreau, Henry David; Britton–purdy, Jedediah;

    3 817 HUF

    3 626 HUF

    20% %discount
    Cancer Biomarkers: The Urokinase Plasminogen Activator System: Molecular Mechanisms and Clinical Relevance

    The Palgrave Handbook of International Political Theory: Volume I

    Williams, Howard; Boucher, David; Sutch, Peter;

    97 628 HUF

    78 102 HUF

    Cancer Biomarkers: The Urokinase Plasminogen Activator System: Molecular Mechanisms and Clinical Relevance

    Castle Skull

    Dickson Carr, John

    5 272 HUF

    4 850 HUF

    next